Terapet announces international collaboration for Heavy Ion Therapy QA

Terapet SA are proud to announce an international collaboration to develop a world-first device for patient-specific QA in heavy ion therapy (HIT). Terapet will be joined in the collaboration by Korean partners Yonsei Cancer Center and Oncosoft Inc, who together bring vital medical expertise and software innovations to be united with Terapet’s novel nuclear imaging […]

Terapet, one of the sponsors at FARO-KOSRO, the largest Asian radiation oncology congresses, in Seoul, South Korea this year

Meet the Terapet SA team and learn more about the world’s first end-to-end quality assurance device, Qualyscan(R) for particle therapy in Seoul, South Korea at this year’s FARO-KOSRO (Federation of Asian Organizations for Radiation Oncology – the Korea Society for Radiation Oncology).We are proud of being this year’s bronze sponsor to one of the largest […]